Bans step therapy delays for neurological conditions

File HF4357 ("Bans step therapy delays for neurological conditions") is before the Minnesota Legislature and has not been decided. Latest step (March 16, 2026): Introduction and first reading, referred to.

Minnesota file HF4357, before the Minnesota Legislature. Still to be decided as of 2026-03-16.

What it does

Neurological patients skip mandatory drug trials, get faster treatment Insurers can no longer force you to try cheaper medications first before covering the drug your neurologist prescribed for conditions like Parkinson's, MS, or epilepsy, letting you start treatment immediately.

The bigger picture

Insurance cost controls shift; premiums or coverage scope may adjust By eliminating step therapy, insurers lose a tool to reduce drug spending, which could increase overall neurological medication costs and potentially lead to higher premiums or narrower formularies for all members.

What to watch

Applies only in Minnesota; federal plans and self-insured employers may not follow The ban covers state-regulated insurers but not federal employee plans, ERISA self-insured employer plans, or Medicare, so some Minnesotans' coverage may remain unchanged.

Official summary

Use of step therapy protocols for the treatment of neurological conditions prohibited.

Read the official record for HF4357

See everything up for a vote · This week in Minnesota · See what we have filed with the clerk